Article

Adding Ezetimibe to a Statin Reduces Cardiovascular Events

A Merck study found patients who received a cholesterol-lowering combination of ezetimibe/simvastatin experienced fewer major cardiovascular events than those taking simvastatin alone.

A Merck study found patients who received a cholesterol-lowering combination of ezetimibe/simvastatin (Vytorin) experienced fewer major cardiovascular events than those taking simvastatin alone.

The results were derived from 18,144 high-risk patients with acute coronary syndrome in the IMPROVE-IT study.

High-risk patients taking statins, including those on treatment with low levels of low-density lipoprotein cholesterol (LDL-C), are still at an increased cardiovascular risk, according to a Merck press release. Therefore, the study’s purpose was to examine whether lowering LDL-C to well under 70 mg/dL by adding ezetimibe to a statin further reduces the risk of cardiovascular events.

At year 7, 32.7% of patients taking Vytorin experienced a primary endpoint event, compared with the 34.7% of patients taking only simvastatin.

“In IMPROVE-IT, the addition of ezetimibe to a statin resulted in a further reduction in cardiovascular events compared to statin therapy alone, which is the first time this has been directly shown in a study of a non-statin cholesterol-lowering medicine,” said study co-chairs Eugene Braunwald, MD, of Harvard Medical School, and Robert Califf, MD, of Duke University. “The IMPROVE-IT data also address an important scientific question about lowering LDL-C to very low levels.”

The results also showed that Vytorin reduced the incidence of death due to a variety of events, including major coronary events, non-fatal stroke, coronary heart disease, non-fatal myocardial infarction, and coronary revascularization occurring 30 days or more after the initial event.

Related Videos
Happy elderly patient with medical health checkup with cardiologist or geriatric doctor. Senior old aging woman with coronary artery heart disease or cardiac illness check-up in clinic - Image credit: Chinnapong | stock.adobe.com
Pharmacist and patient in a retail/community pharmacy setting -- Image credit: Zamrznuti tonovi | stock.adobe.com